Stimulant Medication Safety is Target of New Digital Course and Video Series
Designed to educate patients and caregivers about the safe use of prescription stimulant medication, a new interactive video series and online course focused on ADHD was introduced this week by the Prescription Drug Safety Network and Adlon Therapeutics L.P., a subsidiary of Purdue Pharma L.P.
July 22, 2020
A new interactive video series and digital course1 aim to educate patients with attention deficit hyperactivity disorder (ADHD or ADD) and their caregivers about the safe use of prescription stimulant medications. Adlon Therapeutics and the Prescription Drug Safety Network (PDSN) released these resources in an effort to address prescription drug misuse among adolescents and young adults. Prescription stimulants, which are classified as Schedule II controlled substances by the Drug Enforcement Administration, have a high potential for abuse.
The Prescription Drug Safety curriculum covers the safe use of opioids, stimulants, and anti-depressants and has been shared with more than 600,000 American students since 2017. The new interactive videos and course are part of Adlon Therapeutics’ joint effort with the PDSN to bring the curriculum to high school students with ADHD.
The videos include sample scenarios at home, school, and work involving individuals with ADHD who have been prescribed a stimulant medication. The interactive feature allows viewers to choose options to direct how fictional characters respond to each scenario, which is followed by feedback on the choices selected.
The new interactive digital course covers topics including guidelines for the use of prescription stimulants, how to understand medication labels and guides, how to refuse requests for sharing medication, and substance use disorder information.
“The content in these just-in-time learning modules has been thoughtfully developed to help patients and their caregivers become informed consumers of their prescription medications,” says Kimberly Temp of PDSN. “Providing critical information about stimulant medications in particular is so important to reducing prescription drug misuse in this country.”2
Sources
1Responsible Prescription Stimulant Use. Adlon Therapeutics. https://adlontherapeutics.com/supporting-responsible-stimulant-use/
2Adlon Therapeutics L.P. and the Prescription Drug Safety Network Launch New Resources to Encourage Safe and Responsible Use of Prescription Stimulant Medications. Businesswire (July 2020) https://www.businesswire.com/news/home/20200721005094/en/
